Stock Market News 9 December 2025

Walmart (WMT) Stock on December 9, 2025: Nasdaq Debut, Tech Pivot and 2026 Outlook

On December 9, 2025, Walmart Inc. stock begins trading on the Nasdaq, capping a year in which the world’s largest retailer by revenue has quietly turned into one of Wall Street’s favorite “tech‑adjacent” growth stories. With WMT hovering around $114

9 December 2025

Financial Analysis·Investment·Nasdaq·Stock Market·Walmart

Johnson & Johnson Stock Today: Q3 Beat, Orthopaedics Spin-Off and New Cancer Data Power a 40% Rally

Johnson & Johnson stock (NYSE: JNJ) has quietly turned into one of 2025’s standout blue‑chip winners. As of December 9, 2025, JNJ trades around $202 per share, valuing the company at roughly $486 billion and leaving the stock up close

9 December 2025

Earnings Reports·Healthcare·Investing·Pharma Industry·Stock Market

Salesforce (CRM) Stock on December 9, 2025: Q3 FY26 Beat, AI Agentforce Momentum and What Comes Next

Salesforce, Inc. (NYSE: CRM) is back in the spotlight after reporting record fiscal Q3 2026 results, raising its full‑year outlook, and drawing a wave of analyst and institutional attention. As of December 9, 2025, Salesforce stock is trading around $260

9 December 2025

Artificial Intelligence·Earnings Reports·Investment Analysis·Stock Market·Technology Stocks

JPMorgan Chase (JPM) Stock in December 2025: Price, Latest News, Analyst Forecasts and Key Risks

JPMorgan Chase & Co. (NYSE: JPM) is ending 2025 near record highs and at the center of several major strategic moves – from a $1.5 trillion national‑security financing push to mutual‑fund‑to‑ETF conversions and a landmark crypto IPO mandate. Here’s a

9 December 2025

Financial News·Investment Analysis·JPMorgan Chase·Risk Assessment·Stock Market

Ascendis Pharma (ASND) Stock Slides After Q3 Miss and FDA Delay – What Investors Need to Know on December 9, 2025

Ascendis Pharma A/S (NASDAQ: ASND) is back in the spotlight on December 9, 2025, after its share price slipped again while Wall Street continues to project hefty upside and label the name a “Buy” or “Strong Buy.” The Danish biotech,

9 December 2025

Earnings Reports·FDA Updates·Investment Analysis·Pharma News·Stock Market

BitMine Immersion Technologies (BMNR) Stock Soars as Ethereum Treasury Hits 3.86 Million ETH – Latest News, Forecasts and Risks (Dec. 9, 2025)

BitMine Immersion Technologies, Inc. (NYSE American: BMNR) is back in the spotlight on December 9, 2025, as the Ethereum‑focused treasury stock jumps roughly 8% intraday after confirming it now controls about 3.86 million ETH—more than 3.2% of all Ethereum in

9 December 2025

Cryptocurrency·Ethereum·Financial Forecasts·Investment News·Stock Market

KE Holdings (BEKE) Stock Slides as Buybacks Accelerate: What Q3 2025 Earnings and China’s Housing Slump Mean for Investors

Published 9 December 2025 KE Holdings Inc. (NYSE: BEKE), the Chinese online and offline housing platform behind Lianjia and Beike, is back in the spotlight as its stock trades lower today despite aggressive share repurchases and steady revenue growth. On

9 December 2025

China Economy·Earnings Reports·Investment Insights·Real Estate·Stock Market

Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility

Summit Therapeutics Inc. (NASDAQ: SMMT) continues to trade like a classic high-beta biotech: big promises in lung cancer, plenty of red flags, and a stock price stuck near the lower end of its 52-week range while analysts project eye-popping upside.

9 December 2025

Biotech Industry·Financial News·Investment Analysis·Risk Management·Stock Market

Credo Technology Group (CRDO) Stock: Earnings Blowout, AI Tailwinds, and What Comes Next

Credo Technology Group Holding Ltd (NASDAQ: CRDO) has turned into one of the most closely watched semiconductor names of late, thanks to explosive earnings growth and its strategic position in high-speed connectivity for AI data centers. As of 9 December

9 December 2025

Artificial Intelligence·Earnings Reports·Investment Strategies·Stock Market·Technology Stocks

Linde plc (LIN) Stock on December 9, 2025: 52‑Week Low, CEO Buying and Double‑Digit Upside Price Targets

Linde plc (NASDAQ: LIN), the world’s largest industrial gases company, is having a pivotal moment in the market. On December 9, 2025, the stock is trading near fresh 52‑week lows at the same time its CEO is buying nearly $1

9 December 2025

Company News·Financial Analysis·Investing·Stock Market

Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) has quietly turned into one of 2025’s wilder biotech stories: a tiny oncology name that’s run more than eightfold off its 52-week low, pulled back on a big equity raise, and now sits in the

9 December 2025

Financial News·Investment Analysis·Pharmaceuticals·Stock Market

Legend Biotech (LEGN) Stock Hits New Lows: Oversold CAR-T Leader or Long-Term Opportunity?

As of December 9, 2025, shares of Legend Biotech Corporation (NASDAQ: LEGN) are under heavy pressure even as the company posts strong growth from its flagship CAR-T therapy, CARVYKTI. Here’s a deep dive into the latest news, forecasts, analyst calls

9 December 2025

Biotech·Financial Analysis·Investments·Stock Market